These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6609786)

  • 1. Differential assay of human pancreatic and salivary alpha-amylases in serum using a new fluorogenic substrate.
    Omichi K; Ikenaka T
    Clin Chim Acta; 1984 Apr; 138(2):197-203. PubMed ID: 6609786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inspection of active sites of human salivary alpha-amylase isozymes by means of non-reducing-end substituted maltooligosaccharides with 2-pyridylamino residue.
    Omichi K; Ikenaka T
    J Biochem; 1986 Apr; 99(4):1245-52. PubMed ID: 3486866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential rate assay of human pancreatic and salivary alpha-amylases in serum using two coupled enzymes.
    Omichi K; Ikenaka T
    J Biochem; 1986 Nov; 100(5):1353-8. PubMed ID: 3546280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in transglycosylation between human pancreatic and salivary alpha-amylases.
    Omichi K; Ikenaka T
    J Biochem; 1983 Dec; 94(6):1797-802. PubMed ID: 6608517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a new fluorogenic substrate of alpha-amylases and a simple alpha-amylase assay by HPLC.
    Omichi K; Ikenaka T
    J Biochem; 1983 Apr; 93(4):1055-60. PubMed ID: 6190796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-amylase assay with use of a benzyl derivative of p-nitrophenyl alpha-maltopentaoside, BG5P.
    Satomura S; Sakata Y; Omichi K; Ikenaka T
    Clin Chim Acta; 1988 Jun; 174(3):315-23. PubMed ID: 3134147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of non-reducing-end substituted p-nitrophenyl alpha-maltopentaoside (FG5P) as a substrate for a coupled enzymatic assay for alpha-amylases.
    Omichi K; Ikenaka T
    J Biochem; 1985 Apr; 97(4):977-82. PubMed ID: 3161874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of human salivary alpha-amylase isozymes by high-performance liquid chromatography with a continuous monitor system of the activity.
    Omichi K; Ikenaka T
    Anal Biochem; 1988 Feb; 168(2):332-6. PubMed ID: 3259114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorometric rate assay of alpha-amylase using an intramolecularly-quenched fluorescent substrate (FG5P).
    Omichi K; Ikenaka T
    J Biochem; 1986 Jan; 99(1):291-4. PubMed ID: 3485629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of subtractively modified 2-chloro-4-nitrophenyl beta-maltopentaosides and their application to the differential assay of human alpha-amylases.
    Tokutake S; Oguma T; Tobe K; Kotani K; Saito K; Yamaji N
    Carbohydr Res; 1993 Jan; 238():193-213. PubMed ID: 8431933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of p-nitrophenyl 6(5)-O-benzyl-alpha-maltopentaoside, a substrate for alpha amylases.
    Satomura S; Iwata T; Sakata Y; Omichi K; Ikenaka T
    Carbohydr Res; 1988 May; 176(1):107-15. PubMed ID: 3261202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cyclomaltodextrin glucanotransferase activity by high-performance liquid chromatography using a fluorogenic substrate.
    Satomura S; Omichi K; Ikenaka T
    Anal Biochem; 1986 May; 154(2):449-53. PubMed ID: 2942054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses of 2-chloro-4-nitrophenyl beta-D-maltopentaosides with bulky modification and their application to the differential assay of human alpha-amylases.
    Tokutake S; Kotani K; Saito K; Yamaji N
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2531-6. PubMed ID: 1446374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of ion-exchange chromatography and high-performance liquid chromatography to prepare a substrate for differential assay of human pancreatic and salivary alpha-amylases in serum.
    Omichi K; Ikenaka T
    J Chromatogr; 1987 Sep; 420(1):158-62. PubMed ID: 3499446
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiation of human non-salivary, non-pancreatic alpha-amylase from salivary and pancreatic alpha-amylases by use of FG5P.
    Omichi K; Shiosaki K; Matsubara K; Ikenaka T
    J Biochem; 1990 Apr; 107(4):546-9. PubMed ID: 2358428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the active site of Taka-amylase A: its action on phenyl maltooligosides with a charge at their non-reducing-ends.
    Nagamine Y; Sumikawa M; Omichi K; Ikenaka T
    J Biochem; 1987 Oct; 102(4):767-75. PubMed ID: 3501785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the substrate specificity of Taka-amylase A1. XIV. Preparation of 6-deoxy-6-halogenomaltotrioses and their hydrolysis by Taka-amylase A.
    Omichi K; Matsushima Y
    J Biochem; 1978 Oct; 84(4):835-41. PubMed ID: 309468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human urinary alpha-amylase encoded by the AMY2B gene using a fluorogenic substrate, FG5P.
    Omichi K; Hase S
    J Biochem; 1992 Sep; 112(3):303-5. PubMed ID: 1429515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of aglycone-binding site of human salivary alpha-amylase by means of transglycosylation reactions.
    Omichi K; Hase S; Ikenaka T
    J Biochem; 1991 Mar; 109(3):410-5. PubMed ID: 1880127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatographic assay of the relative activities of serum pancreatic and salivary alpha-amylase using reductively pyridylaminated maltopentaose as a fluorescent substrate.
    Honda S; Ohmura T; Segawa Y; Minematsu T; Kakehi K
    J Chromatogr; 1987 Aug; 419():51-60. PubMed ID: 3499444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.